NASDAQ:PRPO - Precipio Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Precipio Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $2.09 -0.05 (-2.34 %) (As of 01/17/2020 04:00 PM ET) Add Compare Today's Range$2.00Now: $2.09▼$2.1250-Day Range$1.81MA: $2.01▼$2.2552-Week Range$1.65Now: $2.09▼$10.80Volume224,100 shsAverage Volume281,500 shsMarket Capitalization$16.76 millionP/E RatioN/ADividend YieldN/ABeta1.86 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Precipio, Inc, a cancer diagnostics company, provides diagnostic products and services to the oncology market. It also develops a platform to eradicate the problem of misdiagnosis within academic institutions. In addition, the company delivers diagnostic information to physicians and their patients. It has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment, as well as PerkinElmer. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry Analytical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:PRPO Previous Symbol CUSIPN/A CIK1043961 Webhttp://www.precipiodx.com/ Phone203-787-7888Debt Debt-to-Equity Ratio0.05 Current Ratio0.64 Quick Ratio0.60Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$2.86 million Price / Sales5.86 Cash FlowN/A Price / Cash FlowN/A Book Value$2.66 per share Price / Book0.79Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-15,690,000.00 Net Margins-525.32% Return on Equity-94.75% Return on Assets-48.98%Miscellaneous Employees42 Outstanding Shares8,018,000Market Cap$16.76 million Next Earnings Date4/21/2020 (Estimated) OptionableNot Optionable Receive PRPO News and Ratings via Email Sign-up to receive the latest news and ratings for PRPO and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:PRPO Rates by TradingView Precipio (NASDAQ:PRPO) Frequently Asked Questions What is Precipio's stock symbol? Precipio trades on the NASDAQ under the ticker symbol "PRPO." When did Precipio's stock split? How did Precipio's stock split work? Precipio's stock reverse split on Tuesday, June 6th 2017. The 1-30 reverse split was announced on Thursday, May 25th 2017. The number of shares owned by shareholders was adjusted after the market closes on Monday, June 5th 2017. An investor that had 100 shares of Precipio stock prior to the reverse split would have 3 shares after the split. How were Precipio's earnings last quarter? Precipio (NASDAQ:PRPO) posted its quarterly earnings data on Wednesday, November, 13th. The biotechnology company reported ($0.31) EPS for the quarter. The biotechnology company had revenue of $0.78 million for the quarter. Precipio had a negative net margin of 525.32% and a negative return on equity of 94.75%. View Precipio's Earnings History. When is Precipio's next earnings date? Precipio is scheduled to release their next quarterly earnings announcement on Tuesday, April 21st 2020. View Earnings Estimates for Precipio. What price target have analysts set for PRPO? 1 equities research analysts have issued 12-month price targets for Precipio's stock. Their forecasts range from $4.00 to $4.00. On average, they anticipate Precipio's stock price to reach $4.00 in the next twelve months. This suggests a possible upside of 91.4% from the stock's current price. View Analyst Price Targets for Precipio. What is the consensus analysts' recommendation for Precipio? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Precipio in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Precipio. Has Precipio been receiving favorable news coverage? Media headlines about PRPO stock have been trending somewhat positive recently, InfoTrie reports. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Precipio earned a news impact score of 1.7 on InfoTrie's scale. They also gave news articles about the biotechnology company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Precipio. Who are some of Precipio's key competitors? Some companies that are related to Precipio include HTG Molecular Diagnostics (HTGM), BioNano Genomics (BNGO), Arrayit (ARYC), Scientific Industries (SCND), Aethlon Medical (AEMD), Pressure Biosciences (PBIO) and PositiveID (PSID). What other stocks do shareholders of Precipio own? Based on aggregate information from My MarketBeat watchlists, some companies that other Precipio investors own include Portola Pharmaceuticals (PTLA), Biocept (BIOC), MannKind (MNKD), Jaguar Health (JAGX), Inpixon (INPX), TrovaGene (TROV), ACADIA Pharmaceuticals (ACAD), AEterna Zentaris (AEZS), Avid Bioservices (CDMO) and Cellectar Biosciences (CLRB). Who are Precipio's key executives? Precipio's management team includes the folowing people: Mr. Ilan Danieli, Founder, Pres, CEO & Director (Age 47)Mr. Carl R. Iberger, CFO & Sec. (Age 66)Mr. Ahmed Zaki Sabet, Chief Operating Officer (Age 33)Mr. Douglas Sites, VP of SalesMr. Ayman Mohamed, Sr. VP of R&D and Laboratory Operations (Age 34) How do I buy shares of Precipio? Shares of PRPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Precipio's stock price today? One share of PRPO stock can currently be purchased for approximately $2.09. How big of a company is Precipio? Precipio has a market capitalization of $16.76 million and generates $2.86 million in revenue each year. Precipio employs 42 workers across the globe.View Additional Information About Precipio. What is Precipio's official website? The official website for Precipio is http://www.precipiodx.com/. How can I contact Precipio? Precipio's mailing address is 4 Science Park, New Haven CT, 06511. The biotechnology company can be reached via phone at 203-787-7888 or via email at [email protected] MarketBeat Community Rating for Precipio (NASDAQ PRPO)Community Ranking: 2.9 out of 5 ( )Outperform Votes: 254 (Vote Outperform)Underperform Votes: 182 (Vote Underperform)Total Votes: 436MarketBeat's community ratings are surveys of what our community members think about Precipio and other stocks. Vote "Outperform" if you believe PRPO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRPO will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/18/2020 by MarketBeat.com StaffFeatured Article: How can investors find ex-dividend dates?
